Company Name: |
Chongqing Chemieliva Pharmaceutical Co., Ltd.
|
Tel: |
023-67770219 |
Email: |
jessica.hu@chemieliva.com |
Products Intro: |
Product Name:4-Butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]-4H-pyrrolo[3,2,1-ij]quinolin-8-ol CAS:148490-22-6 Purity:95%
|
Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
15002134094 |
Email: |
marketing@targetmol.cn |
Products Intro: |
Product Name:KC-11404 CAS:148490-22-6 Package:50mg/RMB 21300;25mg/RMB 16100;100mg/RMB 27500
|
|
| 4H-Pyrrolo[3,2,1-ij]quinolin-8-ol, 4-butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]- Basic information |
Product Name: | 4H-Pyrrolo[3,2,1-ij]quinolin-8-ol, 4-butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]- | Synonyms: | 4H-Pyrrolo[3,2,1-ij]quinolin-8-ol, 4-butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]-;4-Butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]-4H-pyrrolo[3,2,1-ij]quinolin-8-ol;KC-11404 | CAS: | 148490-22-6 | MF: | C28H38N4O | MW: | 446.63 | EINECS: | | Product Categories: | | Mol File: | 148490-22-6.mol | ![4H-Pyrrolo[3,2,1-ij]quinolin-8-ol, 4-butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]- Structure](CAS/20210111/GIF/148490-22-6.gif) |
| 4H-Pyrrolo[3,2,1-ij]quinolin-8-ol, 4-butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]- Chemical Properties |
Boiling point | 671.7±55.0 °C(Predicted) | density | 1.20±0.1 g/cm3(Predicted) | pka | 10.41±0.40(Predicted) |
| 4H-Pyrrolo[3,2,1-ij]quinolin-8-ol, 4-butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]- Usage And Synthesis |
Description | KC-11404 is an LTB4 inhibitor for the treatment of b-cell leukemias and lymphomas, potently inhibiting histamine, platelet activating factor and 5-lipoxygenase. |
| 4H-Pyrrolo[3,2,1-ij]quinolin-8-ol, 4-butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]- Preparation Products And Raw materials |
|